Clinical trial · Interventional
Game-Based Physical Activity in Childhood Cancer Survivors
Assessing a Game-Based Physical Activity Intervention in Childhood Cancer Survivors: The STEP UP for FAMILIES Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will test whether a game-based exercise plan can help increase the level of physical activity in childhood cancer survivors. The game-based exercise plan will involve participation by both a childhood cancer survivor and his/her parent or caregiver. This study will also look at whether the game-based exercise plan improves childhood cancer survivors' quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Survivors of Childhood Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fitbit Inspire HR | Other | — | UNRESOLVED |
| Questionaires | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- childhood cancer survivors & and one parent/legal guardian
- description
- The study plans to recruit 30 childhood cancer survivors and a parent/legal guardian for each survivor. Participants will be provided with a Fitbit Inspire HR wearable device to record their step counts for two weeks pre-intervention, and over the six-month follow-up period (3-month intervention and 3month follow-up).
- interventionNames
- Other: Fitbit Inspire HR
- Other: Questionaires
Primary outcomes (1)
- measure
- Acceptability of the intervention
- timeFrame
- 3 months
- description
- (i.e., all four responses on the AIM rates as either a 4 or 5 on a 5-point Likert scale of acceptability);
Secondary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 10 Years
- Maximum age
- 16 Years
Show eligibility criteria text
Inclusion Criteria: Childhood cancer survivor: * History of treatment for childhood cancer with cardiotoxic therapy (anthracyclines, chest radiation, total body irradiation) * Off all systemic cancer therapy for ≥ 2 years * Ability to speak and understand English * Ability to complete all protocol assessments * Mobile device with SMS text messaging capability * Ambulatory and able to perform all study requirements * Attained age 10-16 years * Has a parent or legal guardian willing to participate in the study as a dyad * Willing to receive daily SMS text message alerts * Not currently exercising at least 30 minutes per day (5 days/week) * ECOG Performance Status of 0-1 Parent/legal guardian: * Parent or legal guardian of a childhood cancer survivor treated with cardiotoxic therapy (anthracyclines, chest radiation, total body irradiation) * Parent or legal guardian of a child age 10-16 years who is at least 2 years from completion of systemic cancer therapy * Ability to speak and understand English * Ability to complete all protocol assessments * Ability to provide informed consent * Ambulatory and able to perform all study requirements * Access to a mobile device with SMS text messaging capability * Is the parent or legal guardian of a childhood cancer survivor who is willing to participate in this study as a dyad * Willing to receive daily SMS text message alerts * ECOG Performance Status of 0-1 Exclusion Criteria: * Survivors, or parents/legal guardians of survivors, with a medical condition that makes it unsafe to complete study requirements are not eligible for this study. This includes a diagnosis of: * Severe persistent asthma * Known symptomatic coronary artery disease * Musculoskeletal defects that interfere with sustained physical activity * Any medical or psychosocial condition that, in the opinion of the investigator, would jeopardize the health of the participant during study procedures
References
Publications (0)
Data not yet available